Treatment of refractory gastroesophageal reflux disease with radiofrequency energy (Stretta) in patients after Roux-en-Y gastric bypass

S. G. Mattar, F. Qureshi, D. Taylor, P. R. Schauer

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

Background: Morbid obesity is associated with gastroesophageal reflux disease (GERD), which, in most cases, completely resolves after Roux-en-Y gastric bypass (RYGB). Patients with persistent or recurrent symptoms have limited surgical options. This study sought to evaluate the application of the Stretta procedure for patients with refractory GERD. Methods: The medical records of all patients who underwent Stretta for refractory GERD after RYGB were reviewed. Demographic, preoperative, and postoperative reflux data were collected. Data are presented as mean ± standard error of the mean. The t-test was used for comparison purposes. Results: Of 369 patients, 7 received Stretta 27 ± 6 months after RYGB. All were women with a mean age of 49 ± 2 years. All the patients had experienced prebypass GERD symptoms for a duration of 45 ± 8 months. The mean prebypass body mass index was 45 ± 2 kg/m2, and this was reduced to 29 ± 2 kg/m 2 after laparoscopic RYGB (p < 0.001). Before Stretta, all patients underwent a 48-h Bravo pH study, which demonstrated reflux with a mean fraction time of 7% ± 2% for pH lower than 4. After Stretta, five patients had complete resolution of their symptoms, with normalization of pH studies (mean fraction time of 3% ± 0% for pH < 4). The follow-up period after Stretta was 20 ± 2 months. One patient did not have adequate relief of symptoms after Stretta, and one patient was lost to follow-up evaluation. Conclusion: Stretta is a valid option in the treatment of persistent GERD for patients who have undergone gastric bypass. Further study is required to evaluate the long-term efficacy of this procedure.

Original languageEnglish
Pages (from-to)850-854
Number of pages5
JournalSurgical Endoscopy and Other Interventional Techniques
Volume20
Issue number6
DOIs
StatePublished - Jun 2006

Fingerprint

Gastric Bypass
Gastroesophageal Reflux
Therapeutics
tetrachloroisophthalonitrile
Morbid Obesity
Lost to Follow-Up
Medical Records
Body Mass Index
Demography

Keywords

  • Gastric bypass
  • GERD
  • Morbid obesity
  • Radiofrequency
  • Stretta

ASJC Scopus subject areas

  • Surgery

Cite this

Treatment of refractory gastroesophageal reflux disease with radiofrequency energy (Stretta) in patients after Roux-en-Y gastric bypass. / Mattar, S. G.; Qureshi, F.; Taylor, D.; Schauer, P. R.

In: Surgical Endoscopy and Other Interventional Techniques, Vol. 20, No. 6, 06.2006, p. 850-854.

Research output: Contribution to journalArticle

@article{0d196608cad24e7caaaa87986978949f,
title = "Treatment of refractory gastroesophageal reflux disease with radiofrequency energy (Stretta) in patients after Roux-en-Y gastric bypass",
abstract = "Background: Morbid obesity is associated with gastroesophageal reflux disease (GERD), which, in most cases, completely resolves after Roux-en-Y gastric bypass (RYGB). Patients with persistent or recurrent symptoms have limited surgical options. This study sought to evaluate the application of the Stretta procedure for patients with refractory GERD. Methods: The medical records of all patients who underwent Stretta for refractory GERD after RYGB were reviewed. Demographic, preoperative, and postoperative reflux data were collected. Data are presented as mean ± standard error of the mean. The t-test was used for comparison purposes. Results: Of 369 patients, 7 received Stretta 27 ± 6 months after RYGB. All were women with a mean age of 49 ± 2 years. All the patients had experienced prebypass GERD symptoms for a duration of 45 ± 8 months. The mean prebypass body mass index was 45 ± 2 kg/m2, and this was reduced to 29 ± 2 kg/m 2 after laparoscopic RYGB (p < 0.001). Before Stretta, all patients underwent a 48-h Bravo pH study, which demonstrated reflux with a mean fraction time of 7{\%} ± 2{\%} for pH lower than 4. After Stretta, five patients had complete resolution of their symptoms, with normalization of pH studies (mean fraction time of 3{\%} ± 0{\%} for pH < 4). The follow-up period after Stretta was 20 ± 2 months. One patient did not have adequate relief of symptoms after Stretta, and one patient was lost to follow-up evaluation. Conclusion: Stretta is a valid option in the treatment of persistent GERD for patients who have undergone gastric bypass. Further study is required to evaluate the long-term efficacy of this procedure.",
keywords = "Gastric bypass, GERD, Morbid obesity, Radiofrequency, Stretta",
author = "Mattar, {S. G.} and F. Qureshi and D. Taylor and Schauer, {P. R.}",
year = "2006",
month = "6",
doi = "10.1007/s00464-006-0513-6",
language = "English",
volume = "20",
pages = "850--854",
journal = "Surgical Endoscopy",
issn = "0930-2794",
publisher = "Springer New York",
number = "6",

}

TY - JOUR

T1 - Treatment of refractory gastroesophageal reflux disease with radiofrequency energy (Stretta) in patients after Roux-en-Y gastric bypass

AU - Mattar, S. G.

AU - Qureshi, F.

AU - Taylor, D.

AU - Schauer, P. R.

PY - 2006/6

Y1 - 2006/6

N2 - Background: Morbid obesity is associated with gastroesophageal reflux disease (GERD), which, in most cases, completely resolves after Roux-en-Y gastric bypass (RYGB). Patients with persistent or recurrent symptoms have limited surgical options. This study sought to evaluate the application of the Stretta procedure for patients with refractory GERD. Methods: The medical records of all patients who underwent Stretta for refractory GERD after RYGB were reviewed. Demographic, preoperative, and postoperative reflux data were collected. Data are presented as mean ± standard error of the mean. The t-test was used for comparison purposes. Results: Of 369 patients, 7 received Stretta 27 ± 6 months after RYGB. All were women with a mean age of 49 ± 2 years. All the patients had experienced prebypass GERD symptoms for a duration of 45 ± 8 months. The mean prebypass body mass index was 45 ± 2 kg/m2, and this was reduced to 29 ± 2 kg/m 2 after laparoscopic RYGB (p < 0.001). Before Stretta, all patients underwent a 48-h Bravo pH study, which demonstrated reflux with a mean fraction time of 7% ± 2% for pH lower than 4. After Stretta, five patients had complete resolution of their symptoms, with normalization of pH studies (mean fraction time of 3% ± 0% for pH < 4). The follow-up period after Stretta was 20 ± 2 months. One patient did not have adequate relief of symptoms after Stretta, and one patient was lost to follow-up evaluation. Conclusion: Stretta is a valid option in the treatment of persistent GERD for patients who have undergone gastric bypass. Further study is required to evaluate the long-term efficacy of this procedure.

AB - Background: Morbid obesity is associated with gastroesophageal reflux disease (GERD), which, in most cases, completely resolves after Roux-en-Y gastric bypass (RYGB). Patients with persistent or recurrent symptoms have limited surgical options. This study sought to evaluate the application of the Stretta procedure for patients with refractory GERD. Methods: The medical records of all patients who underwent Stretta for refractory GERD after RYGB were reviewed. Demographic, preoperative, and postoperative reflux data were collected. Data are presented as mean ± standard error of the mean. The t-test was used for comparison purposes. Results: Of 369 patients, 7 received Stretta 27 ± 6 months after RYGB. All were women with a mean age of 49 ± 2 years. All the patients had experienced prebypass GERD symptoms for a duration of 45 ± 8 months. The mean prebypass body mass index was 45 ± 2 kg/m2, and this was reduced to 29 ± 2 kg/m 2 after laparoscopic RYGB (p < 0.001). Before Stretta, all patients underwent a 48-h Bravo pH study, which demonstrated reflux with a mean fraction time of 7% ± 2% for pH lower than 4. After Stretta, five patients had complete resolution of their symptoms, with normalization of pH studies (mean fraction time of 3% ± 0% for pH < 4). The follow-up period after Stretta was 20 ± 2 months. One patient did not have adequate relief of symptoms after Stretta, and one patient was lost to follow-up evaluation. Conclusion: Stretta is a valid option in the treatment of persistent GERD for patients who have undergone gastric bypass. Further study is required to evaluate the long-term efficacy of this procedure.

KW - Gastric bypass

KW - GERD

KW - Morbid obesity

KW - Radiofrequency

KW - Stretta

UR - http://www.scopus.com/inward/record.url?scp=33744721803&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33744721803&partnerID=8YFLogxK

U2 - 10.1007/s00464-006-0513-6

DO - 10.1007/s00464-006-0513-6

M3 - Article

VL - 20

SP - 850

EP - 854

JO - Surgical Endoscopy

JF - Surgical Endoscopy

SN - 0930-2794

IS - 6

ER -